Merrimack Pharmaceuticals - Oncology Assets' Unit Acquisition

Merrimack Pharmaceuticals - Oncology Assets raised a round of funding on January 08, 2017. Investors include Ipsen.

Merrimack Pharmaceuticals (NASDAQ: MACK) is a biopharmaceutical company discovering, developing, and commercializing medicines paired with companion diagnostics for the treatment of serious diseases, …

Articles about Merrimack Pharmaceuticals - Oncology Assets' Unit Acquisition: